Inhibitory effect of recombinant fibronectin polypeptide CH50 on invasion and metastasis of melanoma B16 cells

Abstract

In order to investigate the inhibitory effect and mechanism of recombinant polypeptide CH50 on invasion and metastasis of melanoma B16 cells, the recombinant polypeptide CH50 was separated and purified by ion exchange chromatographic technique. The melanoma B16 cells treated with purified CH50 were cultured in vitro, the number was counted at 4, 24, 48 and 72 h and their morphological changes were observed in order to detect their adhesion and spreading abilities. In in vivo study, the melanoma B16 cells were labeled with CFSE and treated with CH50 and then they were injected into mice via mouse-tail veins. After 5 h, the lung tissues were fixed by frozen section. Accumulation and invasion abilities of B16 cells on lung tissues were observed under the fluorescent microscopy. The results showed that the morphological character of B16 cells treated with CH50 changed greatly and the number of B16 cells treated with CH50 decreased significantly (P<0.05). The adhesion and spreading abilities of B16 cells treated with CH50 were weakened obviously and the metastasis foci on lung tissues reduced. It was concluded that the recombinant polypeptide CH50 inhibited invasion and metastasis of melanoma B16 cells on tissues and could be a prospective bio-product in tumor general therapy.

Keywords

fibronectin / recombinant polypeptide / melanoma / tumor

References

[1] ZhangG. M., YangY., HuangB., et al.. Experimental study on therapeutic effect of in vivo expression of Cell: Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma. World J Gastroenterol, 2003, 9(9): 1940-1945

[2] HyoudouK., NishikawaM., UmeyamaY., et al.. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin Cancer Res, 2004, 10(22): 7685-7691

[3] YonedaJ., SaikiI., KobayashiH., et al.. Inhibitory effect of recombinant fibronectin polypeptides on the adhesion of liver-metastatic lymphoma cells to hepatic sinusoidal endothelial cells and tumor invasion. Jpn J Cancer Res, 1994, 85: 723-734

[4] MatsumotoY., SaikiI., MakabeT., et al.. Inhibitory effect of antimetastatic fusion polypeptide of human fibronectin on tumor cell adhesion to extracellular matrices. Jpn J Cancer Res, 1991, 82: 1130-1138

[5] SaikiI., MakabeT., YonedaJ., et al.. Inhibitory effects of fibronectin and recombinant polypeptides on the adhesion of metastatic melanoma cells to laminin. Jpn J Cancer Res, 1991, 82: 1112-1119

[6] FengZ. H., XiaoH., ZhangG. M., et al.. Role of plasmid DNA alone or in combination with IFN-α or CH50 in activation of macrophages. Chin J Microbiol Immunol (Chinese), 2003, 5: 58-62

[7] FanQ., FengZ. H., ZhangG. M., et al.. Effect of recombinant human fibronectin polypeptide CH50 on growth and metastasis of melanoma. Zhongguo Yao Li Xue Bao, 1999, 20(2): 175-178

[8] XiaoH., FengZ. H., ZhangG. M., et al.. Recruitment of immune by cells transfection eucaryotic expressing plasmid of polypeptide CH50 into mice and its role in tumor therapy. Chin J Histochem Cytochem (Chinese), 2002, 2: 135-137